Clinical Trial Update: A Study of TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of TMC435 with sofosbuvir (GS-7977) in chronic hepatitis C genotype 1 infection, including prior null responders and tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PSI-7977 (GS-7977) (sofosbuvir)
• TMC435

Snippet

Sponsor: Janssen R&D Ireland | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2014-10-22